Paper55838
Efficacy of prophylactic gamma-globulin in preventing non-A, non-B post-transfusion hepatitis.
Knodell RG and 3 others. Lancet, 1976. Cited by 164 papers, by iCite.
Cite this record
ConductScience Library. Efficacy of prophylactic gamma-globulin in preventing non-A, non-B post-transfusion hepatitis. Papers, record 55838. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/55838
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hepatitis | Major topic |
| Hepatitis B | Major topic |
| Transfusion Reaction | Major topic |
| gamma-Globulins | Major topic |
| Adult | |
| Child | |
| Child, Preschool | |
| Follow-Up Studies | |
| Hepatitis B Antibodies | |
| Hepatitis B Antigens | |
| Hepatitis B virus | |
| Humans | |
| Jaundice | |
| Placebos |
Source PubMed
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 164 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40573943 | Broadly Neutralizing Antibody Characteristics in Hepatitis C Virus Infection and Implications for Vaccine Design. | Vaccines (Basel) | 2025 | https://conductscience.org/library/papers/40573943 | PubMed |
| 24797372 | Transfusion-associated hepatitis before the screening of blood for hepatitis risk factors. | Transfusion | 2014 | https://conductscience.org/library/papers/24797372 | PubMed |
| 22952447 | Human monoclonal antibody HCV1 effectively prevents and treats HCV infection in chimpanzees. | PLoS Pathog | 2012 | https://conductscience.org/library/papers/22952447 | PubMed |
| 22163337 | Neutralizing antibody response to hepatitis C virus. | Viruses | 2011 | https://conductscience.org/library/papers/22163337 | PubMed |
| 21917891 | Vaccine-induced cross-genotype reactive neutralizing antibodies against hepatitis C virus. | J Infect Dis | 2011 | https://conductscience.org/library/papers/21917891 | PubMed |
| 21034775 | Cross-genotypic polyclonal anti-HCV antibodies from human ascitic fluid. | J Virol Methods | 2011 | https://conductscience.org/library/papers/21034775 | PubMed |
| 19564925 | HCV antibody response and genotype distribution in different areas and races of China. | Int J Biol Sci | 2009 | https://conductscience.org/library/papers/19564925 | PubMed |
| 19321602 | Mutations in hepatitis C virus E2 located outside the CD81 binding sites lead to escape from broadly neutralizing antibodies but compromise virus infectivity. | J Virol | 2009 | https://conductscience.org/library/papers/19321602 | PubMed |
| 18749799 | Internal medicine: non-a, non-B hepatitis. | West J Med | 1985 | https://conductscience.org/library/papers/18749799 | PubMed |
| 18272755 | Broadly neutralizing human monoclonal antibodies to the hepatitis C virus E2 glycoprotein. | J Gen Virol | 2008 | https://conductscience.org/library/papers/18272755 | PubMed |
| 17977972 | Isolation and characterization of broadly neutralizing human monoclonal antibodies to the e1 glycoprotein of hepatitis C virus. | J Virol | 2008 | https://conductscience.org/library/papers/17977972 | PubMed |
| 15136748 | Neutralizing antibodies to hepatitis C virus (HCV) in immune globulins derived from anti-HCV-positive plasma. | Proc Natl Acad Sci U S A | 2004 | https://conductscience.org/library/papers/15136748 | PubMed |
| 12857782 | Managing occupational risks for hepatitis C transmission in the health care setting. | Clin Microbiol Rev | 2003 | https://conductscience.org/library/papers/12857782 | PubMed |
| 11023960 | Passive immunity in prevention and treatment of infectious diseases. | Clin Microbiol Rev | 2000 | https://conductscience.org/library/papers/11023960 | PubMed |
| 10885983 | Risk and management of blood-borne infections in health care workers. | Clin Microbiol Rev | 2000 | https://conductscience.org/library/papers/10885983 | PubMed |
| 6416439 | Prospective study of post-transfusion hepatitis after cardiac surgery in a British centre. | Br Med J (Clin Res Ed) | 1983 | https://conductscience.org/library/papers/6416439 | PubMed |
| 6407830 | Post-transfusion hepatitis and its association with pooled clotting factors. | Eur J Clin Microbiol | 1983 | https://conductscience.org/library/papers/6407830 | PubMed |
| 3146376 | Homologous blood use and conservation techniques for cardiac surgery in the United Kingdom. | BMJ | 1988 | https://conductscience.org/library/papers/3146376 | PubMed |
| 341538 | Antiviral therapy. | Yale J Biol Med | 1977 | https://conductscience.org/library/papers/341538 | PubMed |
| 76494 | Non-A non-B hepatitis. | Br Med J | 1978 | https://conductscience.org/library/papers/76494 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/55838
GET https://conductscience.org/api/papers/v1/55838/authors